Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

The requested reference [87702c0c442157f91752a2d2aea18f51de4da4aa] no longer exists in our database. It has been replaced by the current reference: [9e495dab46c7013708c88b2723ea1098ed48fb74]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main objective of this study is to assess participants\' ability to self-administer subcutaneous doses of maridebart cafraglutide at home using an autoinjector device.
Epistemonikos ID: 25891eb92a2ab480931741dabe8dd9a724258724
First added on: Oct 14, 2026